1. Introduction {#s1}
===============

Amongst the movement disorders, essential tremor is one of the most prevalent disorders. Up to 5% of individuals above the age of 65 years are coping with essential tremor ([@bb0074]). Clinical diagnostic criteria have been developed over the years. The exact clinical definition of essential tremor is however still under debate. Current clinical diagnosis based on the consensus statement of the Movement Disorder Society typically has an estimated error margin of 37% of false-positives ([@bb0056]). Neuroimaging techniques could potentially lower the margin of error in diagnostics by gaining insight into underlying brain pathology and could ultimately be used as a valid diagnostic tool.

The pathophysiology of essential tremor is only partially understood. Thus far, surgical, post-mortem, neurophysiological and animal studies point to the involvement of the inferior olive, the cerebellum, the red nucleus, the thalamus, the cortex and their neurotransmitter systems. These areas make up a network known as the cerebello-thalamo-cortical network or tremor network ([Fig. 1](#f0005){ref-type="fig"}) ([@bb0049]). Olivary afferents travel through the inferior cerebellar peduncle to end in cerebellar nuclei or form synapses with GABAergic inhibitory Purkinje cells in the cerebellar cortex. Purkinje cells send inhibitory projections to the deep cerebellar nuclei including the dentate nucleus. Cerebellar nuclei project via the thalamus to the cerebral cortex, yet other projections end in the red nucleus. The exact mechanisms and possible structural or functional changes within the tremor network are not fully understood. There is an ongoing debate whether essential tremor is primarily (1) a neurodegenerative disorder with actual progressive cell loss, (2) a disorder with localized GABAergic dysfunction, or (3) a disorder caused by abnormal neuronal oscillations within the tremor network ([@bb0018]; [@bb0032]; [@bb0052]; [@bb0069]; [@bb0099]). These hypotheses are not mutually exclusive per se. Neuroimaging techniques might give insight into these three and even other concepts concerning the pathophysiology of essential tremor. Neuroimaging is a rapidly developing field. A variety of imaging studies have been performed in essential tremor patients over the past decade. Our aim is to systematically review these neuroimaging studies in essential tremor and discuss the pathophysiology of essential tremor from a neuroimaging perspective.

2. Methods {#s2}
==========

We queried the OvidSP Embase Classic+Embase and the Ovid MEDLINE® In-Process & Other Non-Indexed Citations from January 1st, 1947 to August 5th, 2013 using the terms 'essential tremor' and 'familial tremor' (Appendix A) in combination with the imaging keywords and their abbreviations stated in [Table 1](#t0005){ref-type="table"}.

Only original English-written articles that recruited both essential tremor patients and healthy controls were included. We identified brain regions and networks associated with essential tremor. Our main research questions for our systematic search were as follows: (1) are results of imaging studies congruent with areas within the known tremor network and valid in the scope of their imaging technique? (2) do the imaging studies help better understand the different hypotheses on the pathophysiology (neurodegeneration, GABA, oscillating network)? and (3) what recommendations can be set for future imaging research arising from current literature?

3. Results {#s3}
==========

A total of 375 abstracts of imaging studies were identified. We excluded abstracts in case they did not address a neuroimaging technique of interest or had deep brain stimulation as main topic. We also excluded studies that did not include patients with postural tremor and studies without a group of healthy controls. A total of 48 imaging studies met our inclusion criteria which account for a total of 713 essential tremor patients divided over 19 structural studies and 29 functional and receptor imaging studies ([Fig. 2](#f0010){ref-type="fig"}). Structural techniques include volumetry, white matter diffusion imaging, magnetic resonance spectroscopy, T2-FLAIR and T2\*-relaxometry. Functional and molecular imaging methods include perfusion, glucose metabolism and receptor imaging.

3.1. Structural imaging in essential tremor {#s3.1}
-------------------------------------------

Structural MRI, as used in current clinical practice, does not reveal significant abnormalities in individual essential tremor patients. Pathological studies however do indicate structural changes ([@bb0070]). More advanced imaging techniques in (sub)groups of patients might be able to reveal structural abnormalities in different brain regions indicative of neurodegenerative changes.

### 3.1.1. Voxel-based morphometry (VBM) {#s3.1.1}

VBM is able to classify and quantify white and grey matter using MRI. It therefore allows analysis of local and total brain volume differences between patient groups ([@bb00117]).

Six papers used VBM to investigate changes in white and grey matter in essential tremor patients compared to healthy controls ([Table 2](#t0010){ref-type="table"}) ([@bb005]; [@bb0012]; [@bb0024]; [@bb0030]; [@bb0067]; [@bb0096]). Two studies did not show any differences after performing whole brain analysis with a 1.5T MRI in a total of 77 essential tremor patients and 59 healthy controls ([@bb0024]; [@bb0030]; [@bb0096]). One of these studies reported grey matter volume reduction of the cerebellar vermis in a subgroup with presence of head tremor (*n* = 20) compared to healthy controls, but reported no differences between patients with and without (*n* = 30) head tremor ([@bb0024]; [@bb0096]). The second study investigated essential tremor by subdividing patients into those with only postural tremor (*n* = 14) and those with additional intention tremor (*n* = 13). Patients with predominant intention tremor showed compared to healthy controls an increase in grey matter in the temporoparietal regions, in the right middle occipital cortex, and in the higher order visuospatial processing areas ([@bb0030]).

The three most recent studies used 3T MRI, enabling higher spatial resolution compared to 1.5T MRI ([@bb005]; [@bb0012]; [@bb0067]). In a total of 49 patients widespread white and grey matter changes in cerebellar and cerebral areas were found. In one of these studies, a post-hoc analysis showed no cerebellar differences but instead found widespread cerebral grey matter reduction in patients with head tremor (*n* = 10, age: 53.1 ± 15.5 years) compared to patients without head tremor (*n* = 10, age: 26.5 ± 5.5 years) ([@bb005]).

In short, one of the six VBM studies revealed isolated volume reduction of the cerebellar vermis in a subgroup of essential tremor patients with head tremor ([@bb0096]). Other studies showed widespread cerebellar and/or cerebral abnormalities. The interpretation of such volume reductions remains uncertain. For example, volume reduction could be interpreted as regional atrophy in neurodegenerative disorders, but especially grey matter volume also strongly depends on age, training and cognitive functioning.

### 3.1.2. Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI) {#s3.1.2}

DWI is an MRI technique in which the image intensity of a voxel reflects the rate of water diffusion at that location, expressed as apparent diffusion coefficient (ADC) or mean diffusivity (MD) ([@bb007]). Diffusion tensor imaging (DTI) can be used to measure diffusion magnitude and to determine axonal direction in the central nervous system. DTI captures the amount of anisotropy of the water diffusion expressed as fractional anisotropy (FA) ([@bb009]). DWI and DTI give an impression of axonal organization and might help to disentangle neuronal circuitries. In pathology--imaging correlations, a reduced FA is accompanied with an increased MD when axon and myelin density are affected ([@bb0081]). In essential tremor, based on the theory of white matter pathology in the cerebellum axonal organization could be disrupted leading to increased diffusion parameters (MD or ADC) and decreased directional diffusion (FA).

A total of eight diffusion studies in essential tremor were found. Three studies performed whole brain voxel-by-voxel comparison ([Table 3](#t0015){ref-type="table"}) ([@bb0063]; [@bb00103]; [@bb00108]); the other studies used regions of interest (ROIs) involved in the tremor network. White matter pathology was determined in six studies with a total of 98 essential tremor patients and 92 healthy controls ([@bb0059]; [@bb0063]; [@bb0083]; [@bb0095]; [@bb00103]; [@bb00108]). Four studies investigating the cerebellum found either an increase in water diffusion (MD, ADC) or a decrease in preferential direction of diffusion (FA) in the inferior cerebellar peduncle, superior cerebellar peduncle and/or dentate nucleus ([@bb0063]; [@bb0083]; [@bb00103]; [@bb00108]). Other regions mentioned were the pons ([@bb00103]; [@bb00108]), thalamus ([@bb00103]) and red nucleus ([@bb0059]; [@bb00108]). Nicoletti and colleagues divided essential tremor groups into short (\<20 years) and long disease duration in order to relate clinical characteristics to diffusion parameters. FA mean values in the dentate nucleus were lower in patients with longer disease duration, however no linear correlation was observed in the whole group. Saini and colleagues did not find any significant correlations between diffusion measures and clinical characteristics (e.g. severity or duration of disease). Two studies investigated the tissue integrity of the basal ganglia, but neither observed significant differences ([@bb0059]; [@bb0080]). Moreover, two studies did not find differences in the cerebellum between essential tremor patients and healthy controls (Buijink et al., 2013; Martinelli et al., 2007). The absence of abnormalities in such studies could be due to their relatively small sample sizes, selection of ROIs (Buijink et al., 2013) and/or relatively short disease duration (median \< 6 years) (Martinelli et al., 2007). Applying voxel-by-voxel analyses ([@bb0063]; [@bb00103]; [@bb00108]), widespread deviations were detected, not only in motor areas but also in non-motor areas like the frontal and temporoparietal areas. Prodoehl and colleagues suggested even the clinical use of diffusion imaging as they were able to differentiate between Parkinson\'s disease, atypical parkinsonism and essential tremor based on a combination of ROIs and their diffusion parameters (mainly basal ganglia and cerebellum) ([@bb0095]).

In summary, six out of eight studies found differences between the patient group and the control group using DWI and DTI. The abnormalities were primarily found in the cerebellar peduncles involved in the information flux and secondarily in the red nucleus. These studies also observed numerous deviations in non-motor areas.

Diffusion parameters are influenced by the distribution of the afferent and efferent fibres in a ROI. Changes in diffusion parameters are associated with pathology but do not necessarily indicate structural axonal loss or demyelination ([@bb0060]). The DWI and DTI studies mentioned above did not identify a particular diffusion parameter to be most sensitive to detect altered diffusion in essential tremor.

### 3.1.3. Magnetic resonance spectroscopy (MRS) {#s3.1.3}

MRS is based on the same physical principles as conventional MRI, although it measures regional magnetic field variation due to different magnetic characteristics of neurochemistry ([@bb008]). The studies below use the ratio between N-acetylaspartate (NAA) and total choline (Cho) or creatine (Cr). A reduction of NAA, or reduced NAA ratio, is associated with neurodegenerative processes ([@bb00111]).

Three studies with a total of 40 patients investigated possible metabolic dysfunction in essential tremor with the help of the MRS technique ([Table 4](#t0020){ref-type="table"}) ([@bb0061]; [@bb0077]; [@bb0088]). ROIs included the cerebellum, thalamus and basal ganglia. Two studies specifically investigating the cerebellum found a decrease in the NAA ratio in the cerebellar cortex compared to healthy controls ([@bb0077]; [@bb0088]). The first study also detected an inverse association between cerebellar cortical NAA ratio and tremor severity ([@bb0077]) whereas the second study did not ([@bb0088]). Pagan and colleagues ruled out severe cerebellar atrophy ([@bb0088]). There were no differences in the thalamus and basal ganglia between patients and healthy controls; however one study investigated lateralization in the thalamus and showed a decrease in NAA ratio contralateral to the predominant tremor side ([@bb0061]).

NAA is here expressed as a NAA ratio with help of cerebellar Cr or Cho levels. It is not possible to rule out an increase of total cerebellar metabolism, including these metabolites, in essential tremor ([@bb0088]). Besides structural deficits, other explanations for the decrease in NAA ratio are abnormalities in neuronal cellular size or neuronal metabolic changes within the cerebellar hemispheres.

### 3.1.4. Other structural imaging {#s3.1.4}

Two studies used T2/T2\*-weighted contrasts in MRI to investigate essential tremor ([Table 5](#t0025){ref-type="table"}) ([@bb0084]; [@bb0086]). Quantitative T2\*-relaxometry is able to determine brain iron concentration. An increased iron concentration has been associated with several neurodegenerative disorders ([@bb00104]). One study in 24 essential tremor patients indicated significant iron accumulation in the bilateral pallidum, substantia nigra and right dentate nucleus ([@bb0084]). Furthermore, a community-based aging study observed more total cerebellar white matter hyperintensity associated with cerebrovascular disease in 33 essential tremor patients compared to 507 controls with T2-weighted FLAIR MRI ([@bb0086]).

3.2. Functional imaging {#s3.2}
-----------------------

Functional imaging studies are able to associate essential tremor with brain activity in rest or during specific tasks. Differences in activation maps might indicate primary oscillations in parts of the outflow circuits or in the compensatory regions. Differences could also be caused by inhibitory or excitatory neurodegenerative changes.

### 3.2.1. Scintigraphic techniques {#s3.2.1}

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are scintigraphic techniques. These are able to measure regional cerebral blood flow (rCBF), regional glucose metabolism or regional binding by employing different radiopharmaceuticals ([@bb0062]). We divide the scintigraphic studies into perfusion imaging and glucose metabolism, and receptor imaging.

#### 3.2.1.1. Perfusion imaging and glucose metabolism {#s3.2.1.1}

Early rCBF scintigraphic studies applied task-related methods to show differences in brain perfusion between essential tremor patients and healthy controls. The PET studies that investigated the rCBF in essential tremor used either the diffusible radiopharmaceutical C~2~^15^O or H~2~^15^O.  SPECT studies investigated rCBF with the radiopharmaceuticals ^99m^Tc-hexamethyl propylene amine oxime (HMPAO) and ^99m^Tc-ethyl cysteinate dimer bicisate (ECD). Importantly, quantitative perfusion PET and steady-state HMPAO SPECT studies show excellent correlations between uptake and actual perfusion ([@bb001]; [@bb0098]). Glucose metabolism was investigated with ^18^F-FDG PET. ^18^F-FDG PET can be used to quantify regional glucose utilization. ^18^F-FDG is transported via the glucose transporter into the cell and is then phosphorylated into FDG-phosphate, which is not further metabolized but accumulates in the cell. PET can regionally quantify the amount of this accumulation. Usually, glucose utilization correlates well with regional synaptic activity ([@bb0087]).

Seven studies used SPECT and PET to determine the rCBF in essential tremor patients ([Table 6](#t0030){ref-type="table"}). All four PET studies, having a total of 28 essential tremor patients and 24 healthy controls, conducted experiments in which the authors regarded the activation associated with tremor to be the summation of a postural motor task and a superimposed tremor. This experimental design was designed to untangle the processes of resting, postural stretching, tremor mimicking and passive wrist moving ([@bb0017]; [@bb0026]; [@bb0058]; [@bb00118]). These four studies were consistent in their findings observing increased bilateral cerebellar activity during both action (tremor) and rest (no tremor) ([@bb0017]; [@bb0026]; [@bb0058]; [@bb00118]). One study showed a suppression of the increased cerebellar activation with alcohol administration together with a reduction of the tremor amplitude ([@bb00118]). Two studies expanded their field of view to include the inferior olive ([@bb0017]; [@bb00118]). Wills and colleagues did not detect altered olivary activity during rest nor during tremor ([@bb00118]). Boecker and colleagues detected an increase in medullary rCBF (region of inferior olive) after alcohol administration ([@bb0017]). Other regions associated with the tremor were the thalamus ([@bb0058]; [@bb00118]), the striatum, the contralateral sensory motor cortex ([@bb0058]) and the red nucleus ([@bb00118]). Postural stretching and passively imposed movements in healthy controls were associated with strictly ipsilateral activation of the cerebellum activation and bilateral thalamus. Glucose metabolism was investigated with ^18^F-FDG reporting hypermetabolism in the medulla and both thalami, but not in the cerebellar cortex ([@bb0050]). Two studies using SPECT to determine rCBF in rest showed different results. One confirmed increased bilateral cerebellar activity ([@bb0029]) whereas the other did not find any significant differences between essential tremor patients and healthy controls ([@bb00102]).

One SPECT study focused on cognitive functioning and related the rCBF with cognitive performances in patients and healthy controls. This study determined differences in test performances but showed no difference in rCBF values ([@bb00102]).

The most consistent finding throughout all scintigraphic rCBF studies is the increased cerebellar activity, mostly bilateral, during posture and rest. One study, using metabolic glucose rate, did not show any increased metabolism in the cerebellum. Here, the absence of cerebellar changes could be related to the analysis technique applied. Relatively large ROIs were included and normalized with respect to mean hemispheric uptake that was higher in the essential tremor group compared to controls (although not statistically significant). PET has been of great influence to form current hypotheses concerning essential tremor. Because of the better resolution of new PET systems, there is a need for renewed functional PET studies in essential tremor.

#### 3.2.1.2. Receptor imaging {#s3.2.1.2}

A total of fifteen studies were found conducting receptor imaging ([Table 7](#t0035){ref-type="table"}). SPECT was mainly used for determining striatal dopamine transporter binding. Currently, ^123^I-FP-CIT SPECT is used in clinical practice to determine nigrostriatal dysfunction in Parkinson\'s disease (PD) and to differentiate PD from other tremor disorders ([@bb0019]). Two relatively small studies indicated a decrease in striatal dopamine binding in essential tremor patients who also exhibited parkinsonian symptoms ([@bb0066]; [@bb00106]).

Moreover, two studies reported a mild reduction in striatal dopamine transporter binding in 60 'pure' essential tremor patients compared to 59 healthy controls although less severe compared to 80 Parkinson\'s disease patients ([@bb0047]; [@bb0054]). The reduced dopaminergic uptake pattern differed between the studies. Alternatively, the majority of DAT-SPECT and DOPA-PET studies did not show any deviations in striatal uptake in a total of 168 essential tremor patients ([@bb0021]; [@bb0020]; [@bb003]; [@bb0036]; [@bb00116]; [@bb004]; [@bb0011]; [@bb0033]; [@bb0055]; [@bb00101]; [@bb0091]). The two largest amongst these studies, with groups of 27 and 32 essential tremor patients, included patients fulfilling the clinical criteria and without any signs of parkinsonism ([@bb004]; [@bb0011]).

One study investigated the GABAergic function, mediating inhibition in motor control, with the help of PET and the GABA~A~ receptor antagonist ^11^C-flumazenil ([@bb0016]). Boecker and colleagues found increased tracer binding in the unilateral cerebellum (dentate nucleus), unilateral ventrolateral thalamus and the unilateral premotor cortex in 8 patients with essential tremor compared to 11 controls.

Another study investigated serotonin transporter binding ([@bb00101]). Using ^123^I-FP-CIT SPECT, Roselli and colleagues found an increased tracer binding in the midbrain of patients with essential tremor compared to those with Parkinson\'s disease and other parkinsonian syndromes ([@bb00101]). However, serotonin transporter binding in essential tremor was comparable to uptake in healthy controls.

### 3.2.2. Functional magnetic resonance imaging (fMRI) {#s3.2.2}

In fMRI, an increase in regional blood oxygenation is used as a proxy for local neuronal activity. The MRI signal is weighted by the difference in magnetic properties of oxygenated and deoxygenated blood. Difference between change in blood flow and oxygen use results in the Blood Oxygen Level-Dependent (BOLD) signal ([@bb0085]). With fMRI it is possible to relate cognitive and motor tasks to specific brain activations. Connections between activated regions in rest can be evaluated by employing resting state-fMRI that is based on spontaneous BOLD signal fluctuations ([@bb0014]).

Of the five fMRI studies in essential tremor, all except one ([@bb0094]) performed whole-brain analyses ([Table 8](#t0040){ref-type="table"}). The first fMRI study was performed in 12 essential tremor patients and 15 healthy controls ([@bb0022]). Tasks were designed to specifically relate tremor with brain activation patterns. These included resting, postural stretching and passive movements of the wrist (excluding proprioceptive afferent activity). The control group was asked to mimic the tremor. Essential tremor patients showed significant increased activations in the bilateral cerebellum and ipsilateral red nucleus during tremor compared to tremor mimicking. Thalamic activity was present during tremor, during tremor mimicking and during passive movement. Olivary activation was not evident.

Two studies performed resting state fMRI (rs-fMRI) in essential tremor ([@bb0042]; [@bb0094]). The first study performed independent component analysis (ICA) on rs-fMRI data in 11 patients, and showed changes in the cerebello-thalamo-cortical network induced by repetitive transcranial magnetic stimulation (rTMS) of the cerebellum. Low cerebello-thalamo-cortical connectivity recovered after 5 days of consecutive rTMS taking the default brain network as the control network ([@bb0094]). The second study used the regional homogeneity (ReHo) measurement of rs-fMRI which investigates regional functional connectivity by calculating temporal correlation of adjacent voxels ([@bb0042]). This study found a decreased ReHo in the cerebellum (anterior and posterior lobes) and the thalamus of tremor patients compared to healthy controls. Non-motor areas, like the prefrontal, the parietal and the insular cortices showed increased ReHo values.

Two other studies with a total of 27 patients concentrated on cognitive functioning in essential tremor ([@bb0025]; [@bb00125]). Despite similar performances between patients and healthy controls in both studies (verbal working memory and Stroop task), essential tremor patients showed increased cerebellar activation compared to controls while executing verbal working memory tasks ([@bb00125]). During the Stroop task patients showed an increased activity in the parieto-prefrontal areas involved in the execution of attentional tasks ([@bb0025]).

In conclusion, one fMRI study reported increased cerebellar activity related to tremor. Using rs-fMRI a decreased functional connectivity in the cerebello-thalamo-cortical network has been determined. How to interpret BOLD changes in the cerebellar cortex is less certain than changes in the neocortex because of its complex anatomical architecture ([@bb0035]).

4. Discussion {#s4}
=============

The imaging studies mainly point to the involvement of the cerebellum in essential tremor. Other identified areas and nuclei have mostly been mentioned as parts of the tremor network and include the brainstem, the red nucleus, the thalamus, the basal ganglia and widespread abnormalities ([Fig. 3](#f0015){ref-type="fig"}). This will be further discussed in Part I of this section. With respect to the different hypotheses regarding the underlying disease mechanisms in essential tremor, some imaging findings are more consistent with general neurodegenerative changes while others are more consistent with localized abnormalities of the GABAergic system. This will be discussed in Part II. Patient selection and recommendations for future imaging in essential tremor are discussed in Part III of this section.

4.1. Part I: are results of imaging studies congruent with existing theories on the 'tremor network'? {#s4.1}
-----------------------------------------------------------------------------------------------------

A majority of the structural and functional findings agree with the pathological involvement of the cerebellum in essential tremor. Although in many neuroimaging studies the cerebellum is the predominant region of interest, studies performing whole brain analysis also indicate cerebellar changes. It is difficult to point to specific areas in the cerebellum because of its complex anatomical architecture and the limitations of analysis techniques applied. Nonetheless, abnormalities in the dentate nucleus, vermis, superior cerebellar peduncle and inferior cerebellar peduncle were associated with essential tremor ([@bb0059]; [@bb0063]; [@bb0083]; [@bb00108]). Clinically, several symptoms point to the involvement of the cerebellum in essential tremor, such as intentional tremor, eye movement abnormalities ([@bb0051]), affected tandem gait ([@bb00109]) and abnormal eye--hand coordination ([@bb00112]). Suppression of essential tremor has been reported after lesioning the cerebellum ([@bb0038]). Cerebellar involvement is also confirmed in neuropathological studies ([@bb0073]; [@bb0072]; [@bb0070]). It is however not clear whether the cerebellar symptoms and pathological changes point to primary involvement of the cerebellum in tremor generation, or merely indicate secondary cerebellar changes. Based on the current imaging studies, it is also difficult to differentiate between primary and secondary changes.

A number of functional studies pointed to thalamic involvement during tremor ([@bb0022]; [@bb0058]; [@bb00118]). Studies that investigated passive movement found thalamic activations and suggested afferent or proprioceptive input to be the main cause of these activations ([@bb0022]; [@bb0058]; [@bb00118]). Stereotactic surgery of the ventral intermediate nucleus (VIM)of the thalamus has been proven to be an effective treatment for essential tremor ([@bb0046]). Intraoperative microelectrode recording show only thalamic tremor activity during postural tremor and not in rest ([@bb1400062207637]). Currently, the role of the thalamus in essential tremor is not entirely clear. Probably, it is mostly seen as a relay station rather than a primary tremor generator.

Only two neuroimaging studies showed abnormalities in the inferior olive area. One study showed an increased glucose metabolism ([@bb0050]) while the other showed an increase in medullary rCBF after alcohol administration ([@bb0017]). Involvement of the inferior olive in tremor generation in the literature comes from animal models that suggest the inferior olive to function as an intrinsic pacemaker ([@bb0068]) and the suggestion that the inferior olive would be prone to intrinsic calcium channel-dependent neuronal oscillations ([@bb0090]). Recently, the first post-mortem study focusing on microscopic changes of the inferior olivary nucleus did not indicate any structural differences ([@bb0071]). Lack of imaging evidence that points to the involvement of the olivary nucleus might be due to its anatomical location picking up physiological noise and/or the use of incorrect functional parameters.

Abnormalities in the red nucleus are reported in two diffusion studies and one fMRI study. ([@bb0022]; [@bb0059]; [@bb00108]). Because of its tight functional connection with the cerebellum and inferior olive, the red nucleus is hard to study in isolation.

Most scintigraphic studies looking into the basal ganglia found no dopaminergic deficits in essential tremor ([@bb003]; [@bb004]; [@bb0011]; [@bb0020]; [@bb0021]; [@bb0036]; [@bb0053]; [@bb00116]) while two studies measured slight abnormalities ([@bb0047]; [@bb0054]). One study reported iron accumulation in the basal ganglia ([@bb0084]). The basal ganglia are not often primarily associated with tremor generation in essential tremor.

In current literature, non-motor symptoms have been increasingly associated with essential tremor ([@bb0057]). Especially in structural VBM and DWI studies non-motor areas like frontal and temporoparietal areas, which are involved in cognitive and visuospatial processing, are associated with essential tremor ([@bb005]; [@bb0012]; [@bb0030]; [@bb0063]; [@bb0063]; [@bb0067]; [@bb0067]; [@bb00103]; [@bb00108]; [@bb00108]). Increased grey matter volume could imply compensatory processes such as those found in the visuospatial processing areas ([@bb0067]). Diffusion studies however showed a widespread increase of white matter diffusion, opting for extensive white matter dysfunction. One rs-fMRI study found abnormalities in non-motor areas with functional connectivity analysis ([@bb0042]). The cognitive deficits in essential tremor affect attention, working memory and executive functions. These cognitive performances are known to be associated with regional cerebellar abnormalities ([@bb0013]; [@bb0039]). One fMRI study investigated essential tremor during the Stroop task, assessing attentional control and evaluating executive functions, and found the involvement of several 'cognitive' cortical areas but no cerebellar areas ([@bb0025]). The authors hypothesized that the increased cortical activity suggests an increase in cognitive effort due to a more subtle cerebellar dysfunction.

4.2. Part II: do the imaging techniques help to understand the pathophysiology of essential tremor better? {#s4.2}
----------------------------------------------------------------------------------------------------------

Essential tremor has been considered to be primarily a neurodegenerative disorder, with progressive cell loss, in part of the literature. Some pathoanatomical cerebellar investigations support structural changes. Post-mortem studies showed an increased number of Purkinje cell axonal swellings (torpedoes) and actual Purkinje cell loss in the cerebellum ([@bb0073]; [@bb0072]; [@bb0070]), but others have not been able to confirm these findings ([@bb00100]; [@bb00110]). Neighbouring non-Purkinje cell abnormalities like abnormal axonal processes of basket cells and Bergman gliosis were found in other post-mortem studies ([@bb0040]; [@bb00107]). Several structural imaging studies observed widespread abnormalities, changes not only included cerebellar areas but also frontal and temporoparietal areas ([@bb005]; [@bb0063]; [@bb0067]; [@bb00103]; [@bb00108]). These findings might support a more generalized neurodegenerative nature of essential tremor based on widespread alterations in the brain rather than specific cerebellar cell loss. Other structural imaging studies showed an isolated reduction in cerebellar volume([@bb0096]) and an increase in cerebellar diffusion supporting a local 'purkinjopathy' ([@bb0059]; [@bb0063]; [@bb0083]; [@bb00108]). Metabolic changes, shown with MRS, support regional neuronal loss in the cerebellar cortex ([@bb0077]; [@bb0088]). Regional deficits however, do not necessarily indicate the primary site of pathology.

In essential tremor the limited symptomatology and the absence of a consistent neuropathological substrate lead one to suspect disease mechanisms other than neurodegeneration. Drugs that facilitate GABA transmission, like primidone, gabapentin and benzodiazepines, are effective treatments in essential tremor ([@bb00120]). Moreover, the explicit role of ethanol, which is a GABA~A~ receptor agonist and considered to reduce tremor in essential tremor patients, implies the involvement of the GABA system in essential tremor ([@bb0017]; [@bb00121]). The GABAergic hypothesis which is the abnormal functioning of the inhibitory neurotransmitter GABA is most often considered in light of neurodegenerative Purkinje cell loss. Alternatively, one could consider abnormalities of GABA receptor subtypes or other isolated biochemical changes related to GABA function ([@bb0016]; [@bb0064]; [@bb0078]). Post-mortem investigations in the dentate nucleus showed reduction of GABA~A~ and GABA~B~ receptor expression. Additional findings indicated loss of GABA~B~ receptor messenger RNA transcripts in the dentate nucleus cells which could account for the loss of GABA receptors ([@bb0089]). In genetic animal research, GABA~A~-alpha1 receptor knockout mice presented phenotypic similarities with essential tremor ([@bb0064]). Our literature search identified PET/SPECT studies that are in accordance with the GABA hypothesis ([@bb0015]). These studies showed obvious cerebellar overactivity during tremor manifestation and rest, and activities that normalized after ethanol intake along with the tremor reduction. Two PET studies specifically investigated the GABAergic system. These reported a diffuse increased binding at the benzodiazepine receptor site (part of the GABA~A~ complex) in the ventrolateral thalamus, the premotor cortex and the cerebellum (dentate nucleus) ([@bb0016]; [@bb0048]). The authors suggested that an increased availability of benzodiazepine receptor sites might reflect a reactive receptor upregulation due to a localized GABAergic deficit or reflect functional abnormalities at the receptor level ([@bb0016]; [@bb0048]). Gironell and colleagues showed a positive relationship between tremor severity and cerebellar GABA~A~ receptor binding ([@bb0048]). Theoretically, cerebellar functional disturbances could cause secondary cerebellar damage ([@bb0032]). Therefore, the GABA hypothesis does not disagree with Purkinje cell loss or other morphological changes in essential tremor. These results warrant further research to determine the role of GABA in essential tremor. Currently, GABA MRS imaging is a growing field which might lead to meaningful insights in essential tremor ([@bb0082]).

Another common hypothesis is the oscillating network hypothesis that implies excessive neuronal oscillations throughout the whole cerebellar circuit resulting in entrainment. This theory is nowadays evolving towards a theory that holds multiple oscillations interacting in the tremor network ([@bb0032]; [@bb0052]). Oscillations are mostly investigated with high temporal resolution methods relating EEG and thalamic local field potential to tremor measured by EMG with coherence analysis ([@bb0092]; [@bb0097]). There are theories that point to the inferior olive as the origin of the faulty oscillations ([@bb0049]). PET and fMRI studies show a constant overactivity of the cerebellum. This might be either due to abnormalities in the cerebellum or due to an abnormal cerebellar afferent input from the inferior olive ([@bb0017]; [@bb0015]; [@bb0022]; [@bb0026]; [@bb00118]). We know that the inferior olive is under the modulating influence of GABA; a deﬁciency in the GABAergic system could increase synchronicity. The olivary involvement is not clearly determined in functional imaging studies, although it does not seem to show structural changes. It is important to conduct imaging research across multiple regions of the brain using functional and effective (causal) connectivity techniques. For example, dynamic causal modelling in fMRI reveals temporal dependency of activity between areas. By combining imaging techniques with modalities that offer high temporal resolution it might be possible to capture the dynamic behaviour of the oscillations.

4.3. Part III: what recommendations can be set for future imaging research arising from current literature? {#s4.3}
-----------------------------------------------------------------------------------------------------------

### 4.3.1. Patient selection {#s4.3.1}

In some studies essential tremor patients showed additional neurological symptoms. For example, inclusion of essential tremor patients with concomitant parkinsonism could explain DAT deficits in two studies ([@bb0066]; [@bb00106]). Essential tremor not only might be confused with other tremulous disorders, but also might be a heterogeneous disorder. This may explain the variability in clinical measures, epidemiological measures, conflicting pathological findings, differences in medication response, and yet indecisive data on genetics ([@bb0043]). Also, inconsistent neuroimaging findings implicate a spectrum of disorders with (initially or eventually) similar phenotypes but different structural or functional changes. The classical essential tremor criteria are evolving and three sub-classifications have been proposed: sporadic, hereditary and senile essential tremors (tremor onset after age of 65 years) ([@bb0032]). Future imaging research could benefit using these sub-classifications with appropriate group sizes. Inclusion based on more stringent clinical selection like disease duration will lead to more firm conclusions.

### 4.3.2. Imaging limitations and recommendations with respect to imaging techniques {#s4.3.2}

Although the spatial resolution of the clinical imaging techniques is moderate to good (e.g. fMRI 2--3 mm, SPECT 6--10 mm, PET 3--6 mm), small regions that are of interest like nuclei in the brainstem still may not be detectable ([@bb0035]; [@bb0037]). In the near future, more accurate techniques like 7T MRI will become available offering new opportunities in neuroimaging research. fMRI sequences are known for their limited temporal resolution taking up to 2--3 s for a whole brain scan, while tremor frequency varies between 4 and 12 Hz. To capture tremor modulations it is possible to combine techniques, like multimodal EEG/EMG--fMRI. An alternative option is to confine the analysis to a specific region in the brain and register with high temporal resolution. In order to directly relate essential tremor to the BOLD signal one study introduced EMG--fMRI ([@bb0027]). Simultaneous EMG--fMRI was performed in 6 essential tremor patients who had undergone unilateral thalamotomy. An EMG based regressor revealed ipsilateral cerebellar and contralateral thalamic activations. Also, other EMG--fMRI studies have proven to be useful for imaging movement disorders ([@bb00113]; [@bb00115]; [@bb00114]). In addition, the fact that brain activations may be related not only to pathological output, but also to afferent input as a result of the ongoing movements, is often not taken into account. By applying an external perturbation, for instance TMS or another perturbation technique with well-known properties, it is possible to challenge the system and perhaps distinguish cause-and-effect ([@bb0094]).

The analysis techniques are also improving. These were originally developed for cerebral cortical areas. Recently, specific toolboxes have been developed to specifically investigate the cerebellum and brainstem ([@bb0010]; [@bb0035]; [@bb0034]). In some cases in functional imaging studies it is useful to add an extra condition as localizer, targeting functionally specific ROIs ([@bb0093]). Furthermore, analysis techniques move towards network detection and focus more on connectivity circuits instead of individual structures.

So far, only ^123^I-FP-CIT SPECT has gained a recognized role in clinical practice for differentiating essential tremor and parkinsonian diseases ([@bb0011]; [@bb0028]). The clinical impact of other imaging techniques is modest. Imaging results in individual patients are variable and these techniques cannot (yet) be adopted in clinical practice.

5. Conclusion {#s5}
=============

In essence, contemporary clinical diagnosis of essential tremor is based on clinical assessment of the phenomenological characteristics and its course. Essential tremors\' high prevalence, its unclear association with additional comorbidity and its variation in clinical presentation cause misdiagnosis. Neuroimaging results are congruent with areas within the tremor network. Functional imaging studies that provide insights in regional cerebral blood flow and metabolism point to the cerebello-thalamo-cortical outflow pathways, with cerebellar involvement as the most consistent finding. Structural imaging studies show more widespread alterations. Theories on the pathophysiology of essential tremor, including the neurodegenerative, GABAergic and oscillatory network hypotheses, are not mutually exclusive and should be further elucidated. GABAergic dysfunction is perhaps the primary factor involved in the pathophysiological hypotheses and is worthwhile investigating more intensively. Inconsistencies of study results can be attributed to patient selection. Future research requires more stringent inclusion criteria and application of tailored analysis techniques that focus on connectivity in brain networks. The rapid developments of imaging techniques in combination with other tremor recording modalities could lead to a diagnostic imaging paradigm for essential tremor in the future.

Appendix A. Supplementary materials {#sec1023}
===================================

Supplementary materials for Neuroimaging essentials in essential tremor: A systematic review.

![Tremor network: A) inferior olive; B) dentate nucleus; C) red nucleus; D) tha- lamus; E) motor cortex.](gr1){#f0005}

![Included imaging studies are divided into structural methods and functional and molecular methods.](gr2){#f0010}

![The tremor network weighted, based on number of studies finding abnormal- ities against total amount of studies that investigated the region. A) Inferior olive; B) dentate nucleus; C) red nucleus; D) thalamus; E) widespread abnormalities.](gr3){#f0015}

###### 

Keywords and abbreviations used in the literature search

  Keyword                                      Abbreviation
  -------------------------------------------- --------------
  Magnetic Resonance Imaging                   MRI
  Voxel-Based Morphometry                      VBM
  Diffusion Weighted Imaging                   DWI
  Functional Magnetic Resonance Imaging        fMRI
  Positron Emission Tomography                 PET
  Single-Photon Emission Computed Tomography   SPECT
  Magnetic Resonance                           \-
  Tomography                                   \-
  Scintigraphic Imaging                        \-

###### 

Voxel-based morphometry (VBM).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                        Clinical features      Imaging                                                                                                                      
  --------------------- ---------------------- ------------------ -------------- ---- ---- -------------------------------------------------------------------------------- ------------------------------------------
  [@bb0030],            14 ET--PT 54.1(13.1)   14 HC 51.1(14.6)   UE PT, UE IT   D    --   --                                                                               Whole brain, GM, WM

  1.5T                  13 ET--IT 61.8(10.3)   13 HC 64.7(7.0)                        ↑    GM ET--IT: temporoparietal junction, unilateral occipital cortex                 *P*cor \< 0.05

                                                                                                                                                                            

  [@bb0096]             30 ET-a 61.5(16.5)     32 HC 66.2(8.1)    UE, head       D    --   --                                                                               Whole brain GM; ROI 3 lobules cerebellum

  and [@bb0024], 1.5T   20 ET-h 70.6(7.6)                                             ↓    GM h-ET: cerebellar anterior lobe and vermis                                     *P*cor \< 0.001

                                                                                                                                                                            

  [@bb005], 3T          10 ET 53.1(12.7)\      17 HC 40.7(16.5)   UE, LE,\       D    ↓    GM ET bilateral cerebellum hemispheres, vermis, frontal lobes, occipital lobes   Whole brain, GM, WM, ICV\
                        10 ET-h 26.5(5.5)                         head, voice                                                                                               *P*unc \< 0.001

                                                                                                                                                                            

  [@bb0012], 3T         19 ET 69.8(9.4)        20 HC 68.9(10.0)   UE, head       Ls   ↓↑   WM right cerebellum, left medulla, right parietal lobe,\                         Whole brain GM, WM\
                                                                                           right limbic lobe                                                                *P*unc \< 0.001

                                                                                      ↓↑   GM bilaterally cerebellum, bilateral parietal lobes,\                            
                                                                                           right frontal lobe, right insula                                                 

                                                                                                                                                                            

  [@bb0067], 3T         10 ET 63.4(8.7)        13 HC 65.3(11.1)   ?              --   ↓    Caudate, middle temporal pole, insula, precuneus, STG                            Whole brain GM (basic and DARTEL)

                                               10 PD 67.3(8.8)                        ↑    Middle temporal gyrus, precentral gyrus                                          *P*unc \< 0.05
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

a, arm tremor; BG, basal ganglia; cor, multiple comparison corrected; Cri, criteria; D, [@bb0031]; ET, essential tremor; GM, grey matter; h(ead), head tremor; HC, healthy controls; ICV, intracranial volume; IT, intention tremor; LE, lower extremity; Ls, [@bb0075]; *P*cor, multiple comparison correction; PD, Parkinson\'s disease; PT, postural tremor; SD, standard deviation; ROI, region of interest; STG, superior temporal gyrus; UE, upper extremity; *P*unc, multiple comparison uncorrected; voice, voice tremor; vs, versus; WM, white matter.

###### 

Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                         Clinical features   Imaging                                                                                                                                                         
  ---------------------- ------------------- -------------------- ------------- ---- ---- ----------------------------------------------------------------------------------------------- ------------------ ------------------------------------------------------------------------------------------------------------------
  [@bb0080], 1.5T DWI    10 ET 66(11)        10 HC 60(8)          UE,\          D    --   --                                                                                              ADC\               ROI: pons, MCP, cerebellar WM, DN, red nucleus, thalamus, caudate, putamen, pallidum, frontal and precentral WM\
                                                                  voice, head                                                                                                             b = 300, 600,\     *P*unc \< 0.05
                                                                                                                                                                                          900 s/mm^2^        

                                                                                                                                                                                                             

  [@bb00108], 1.5T DTI   10 ET 52.8(11.5)    8 HC 51.3(11.1)      UE,\          Fi   ↓    Bilateral cerebellum, right pons, left retrorubral area of the midbrain and bilateral deep WM   FA\                WM voxel wise\
                                                                  head                                                                                                                    b = 1000 s/mm^2^   *P*unc \< 0.05

                                                                                                                                                                                                             

  [@bb0083],             25 ET 62.9(9.5)     15 PD 46.6(6.3)      UE            D    ↑    MD: SCP                                                                                         FA, MD             ROI: red nucleus, MCP, SCP,

  1.5T DTI                                   15 HC 62.4(5.4)                         ↓    FA: DN, SCP                                                                                     b = 900 s/mm^2^    DN, cerebellar WM, ventrolateral thalamus\
                                                                                                                                                                                                             *P*unc \< 0.001

                                                                                                                                                                                                             

  [@bb0063], 3T DTI      14 ET 61.2(12.0)    20 HC 60.2(8.1)      UE            D    ↑    ROI: MD bilateral ICP\                                                                          FA, MD\            ROI: MCP, SCP, ICP FWE *P*cor \< 0.05
                                                                                          Voxel wise/TBSS: Widespread MD                                                                  b = 1000 s/mm^2^   

                                                                                     ↓    ROI: FA unilateral ICP                                                                                             Voxel wise, TBSS TFCE *P*cor \< 0.05

                                                                                                                                                                                                             

  [@bb0059], 3T DTI      15 ET 65.1(11.4)    15 HC 62.1(7.6)      UE            Ls   ↑    ADC: red nucleus                                                                                ADC, FA\           ROI: caudate, putamen, globus pallidus, thalamus, red nucleus, substantia nigra
                                                                                                                                                                                          b = 800 s/mm^2^    

                                                                                                                                                                                                             

  [@bb0023], 3T DTI      8 ET 48.4(17.8)     5 HC 42.8(14.4)\     UE            Ba   --   --                                                                                              FA, MD\            ROI cerebellum *P* \< 0.05
                                             7 FCMTE 39(12.2)                                                                                                                             b = 700 s/mm^2^    

                                                                                                                                                                                                             

  [@bb00103], 3T DTI     20 ET 38.2(16.5)    17 HC 40.7(16.5)     UE,\          D    ↑    ROI AD: ALIC, bilateral SCP, right ICP, CS\                                                     MD, RD, AD, FA\    ROI: Corpus callosum, SCP, MCP, ICP, CS, ALIC *P*unc \< 0.05 Voxel wise TBSS *P*cor \< 0.05
                                                                  head, voice             ROI MD: right ALIC, left CS\                                                                    b = 800 s/mm^2^    
                                                                                          TBSS MD, RD: right frontoparietal WM\                                                                              
                                                                                          TBSS RD: right frontoparietal WM, internal/external capsule\                                                       
                                                                                          TBSS AD: cerebral WM, thalamus, brainstem, internal/external capsule, cerebellar peduncles                         

                                                                                     ↓    ROI FA: left SCP, right CS                                                                                         

                                                                                                                                                                                                             

  [@bb0095], 3T DTI      14 ET 61.6(11.0)    15 PD 62.7(7.7)\     UE            D         Combining measures to differentiate between the groups^\*^                                      FA, RD, LD, MD\    ROI: Caudate, putamen, GP, SN, RN, SCP, MCP, ICP, DN
                                             14 MSAp 64.3(8.9)\                                                                                                                           b = 1000 s/mm^2^   
                                             12 PSP 70.7(5.6)\                                                                                                                                               
                                             17 HC 62.9(9.0)                                                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AD, axial diffusivity; ADC, apparent diffusion coefficient; ALIC, anterior limb of internal capsule; Ba, [@bb006]; b-value, scaling value for attenuating effect; cor, multiple comparison corrected; Cri, criteria; CS, corticospinal tract; D, [@bb0032]; DN, dentate nucleus; FA, fractional anisotropy; FCMTE, familial cortical myoclonic tremor with epilepsy: (F)ET, (familial) essential tremor; Fi, [@bb0044]; FWE, family wise error; GP, globus pallidus; HC, healthy controls; head, head tremor; LD, longitudinal diffusivity; Ls, [@bb0075]; MCP SCP ICP, middle/superior/inferior cerebellar peduncle; MD, mean diffusivity; MSAp, multiple system atrophy with prominent parkinsonian signs; PD, Parkinson\'s disease; PSP, progressive supranuclear palsy; RD, radial diffusivity; RN, red nucleus; ROI, region of interest; SD, standard deviation; sn, substantia nigra; TBSS, tract-based spatial statistics; TFCE, threshold-free cluster enhancement; UE, upper extremity; *P*unc, multiple comparison uncorrected; voice, voice tremor; vs, versus; WM, white matter. ^\*^Not included in [fig. 2](#f0010){ref-type="fig"}

###### 

Magnetic resonance spectroscopy (MRS).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Clinical features   Imaging                                              
  ----------------- ------------------- ----------------- ---- ---- ---- ------------------- -----------------------------------------------------------------------------------
  [@bb0077], 1.5T   16 ET 66(18)        11HC 60(24)       UE   Ls   ↓    Cerebellar cortex   ROI: Cerebellar cortex, cerebellar WM, vermis, thalamus, basal ganglia\
                                                                                             NAA/Cr ratio\
                                                                                             Slice thickness 15 mm\
                                                                                             *P* unc \< 0.05

                                                                                             

  [@bb0088], 1.5T   10 ET 59.4(18.7)    10 HC 57.2(17)    UE   Ba   ↓    Both cerebellar\    ROI: Vermis midline, dentate nuclei, cerebellar hemispheres, red nuclei, thalami\
                                                                         hemispheres         NAA/Cho ratio, NAA/Cr ratio\
                                                                                             Slice thickness 15 mm\
                                                                                             *P* cor \< 0.05\

                                                                                             

  [@bb0061], 1.5T   14 ET 38.6(12.8)    9 HC 35.4(11.7)   UE   Ls   --   --                  ROI: Single voxel ROI thalami\
                                                                                             NAA/Cr, Cho/Cr\
                                                                                             Slice thickness 13 mm\
                                                                                             *P* unc \< 0.05
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ba, [@bb006]; cor, multiple comparison corrected; Cho, choline; Cr, creatine; Cri, criteria; ET, essential tremor; HC, healthy controls; NAA, N-acetylaspartate; head, head tremor; Ls, [@bb0075]; Med: ?, medication status unknown; ROI, region of interest; SD, standard deviation; UE, upper extremity; *P*unc, multiple comparison uncorrected; VBM, voxel based morphometry; voice, voice tremor; vs, versus; WM, white matter.

###### 

Other structural imaging.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Clinical features    Imaging                                                                                       
  ----------------- -------------------- --------------------- ------------ ---- --- ------------------------------------------------- --------------------------------------------------------------------------------------------
  [@bb0086], 1.5T   33 ET \*79(74--87)   507 HC \*78(75--82)   UE           Ls   ↑   Total WMH\                                        T2-FLAIR MRI\
                                                                                     Cerebellar WMH, temporal WMH                      WMH in ROI: cerebellum, frontal lobe, basal ganglia, occipital, parietal, temporal lobes \
                                                                                                                                       *P*cor \< 0.05

                                                                                                                                       

  [@bb0084], 3T     24 ET 64.3(10.0)     25 HC 64.2(9.3)       UE, head,\   D    ↑   Bilateral globus pallidus, substantia\            Whole brain R2\* (1/T2\*) maps\
                                                               dys                   nigra, right dentate nucleus (*P*unc \< 0.001)\   *P*unc \< 0.001 and FWE *P* \< 0.05
                                                                                     Bilateral pallidum (FWE *P* \< 0.05)              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cor, multiple comparison corrected; Cri, criteria; D, [@bb0031]; dys, dystonic features; ET, essential tremor; FWE, family wise error; head, head tremor; HC, healthy controls; Ls, [@bb0075]; ROI, region of interest; SD, standard deviation; UE, upper extremity; *P*unc, multiple comparison uncorrected; vs, versus; WMH, white matter hyperintensities.

###### 

Perfusion scintigraphy: positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                    Clinical features                       Imaging                                                                                                                                                                                                    
  ------------------------------------------------- --------------------------------------- ------------------------------------------------------------------ ---------------------- ----- ------------------------------ --- ----------------------------------------------------------------------- ---------------------------------------
  [@bb0026], C~2~^15^O PET: rCBF                    4 ET 56(?)                              4 HC 62(?)                                                         UE                     M     ET right arm posture vs rest   ↑   Bilateral cerebellum, contralateral SMC, bilateral PMC                  FOV axial 10.5 cm\
                                                                                                                                                                                                                                                                                                       *P*unc \< 0.05

  ET passively vs rest                              ↑                                       Contralateral SMC, bilateral PMC                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                       

  [@bb0058], C~2~^15^O PET: rCBF                    11 ET \*63.8(30--80)                    8 HC \*57.1(29--73)                                                UE                     Fin   ET vs CO in rest               ↑   Bilateral cerebellum                                                    FOV axial 10.13 cm\
                                                                                                                                                                                                                                                                                                       Cerebellum FOV

  ET right arm posture vs rest                      ↑                                       Bilateral cerebellum, contralateral striatal, thalami, SMC         *P*cor \< 0.05\                                                                                                                         
                                                                                                                                                               Rest *P*cor \< 0.025                                                                                                                    

                                                                                                                                                                                                                                                                                                       

  [@bb0050], ^18^F-FDG PET: rCMGlc                  8 ET \*50(25--72)                       10 HC \*44\                                                        UE                     --    ET vs CO in rest               ↑   Medulla, thalami                                                        ROI:\
                                                                                            (24--66)                                                                                                                                                                                                   Medulla, thalami,\
                                                                                                                                                                                                                                                                                                       cerebellar cortices\
                                                                                                                                                                                                                                                                                                       *P*unc \< 0.05

                                                                                                                                                                                                                                                                                                       

  [@bb00118], [@bb0119], H~2~^15^O PET: rCBF        7 ET \*49.4(28--74)                     6 HC \*51.1(24--70)                                                UE                     Fin   ET vs CO in rest               ↑   Bilateral cerebellum, thalamus                                          FOV 10.65 cm\
                                                                                                                                                                                                                                                                                                       Include ION\
                                                                                                                                                                                                                                                                                                       *P*cor \< 0.05\
                                                                                                                                                                                                                                                                                                       Rest *P*unc \< 0.05

  ET right arm posture vs rest                      ↑                                       Bilateral cerebellum, midbrain (red nucleus), bilateral thalamus                                                                                                                                           

  ↓                                                 Inferior temporal and occipital areas                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                       

  [@bb0017], H~2~^15^O PET: rCBF                    6 ET 54(14)                             6 HC 45(18)                                                        UE                     Fin   ET vs CO in rest               ↑   *Before ethanol*: bilateral cerebellum\                                 Axial FOV10.65 cm\
                                                                                                                                                                                                                               *After ethanol*: less reduction in cerebellar rCBF, medulla oblongata   Including ION\
                                                                                                                                                                                                                                                                                                       *P* \< 0.001

  ET right arm posture vs rest                      ↑                                       *Before ethanol*: bilateral cerebellum, cerebellar vermis\                                                                                                                                                 
                                                                                            *After ethanol*: cerebellar vermis                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                       

  [@bb00102], Technetium-99m- HMPAO SPECT: rCBF     11 ET ?                                 9 HC ?                                                             UE, head,\             Ba    ET vs CO in rest               −   --                                                                      ROI: 47 cortical, and cerebellar ROI\
                                                                                                                                                               voice                                                                                                                                   cortex/occipital ratio

                                                                                                                                                                                                                                                                                                       

  [@bb0029], ^99m^Tc-ethyl cysteinate SPECT: rCBF   5 ET 67.4(7.1)                          5 PT\                                                              UE                     D     ET vs CO in rest               ↑   Bilateral cerebellar, left inferior frontal gyrus                       *P*cor \< 0.02\
                                                                                            52.2(10.2)\                                                                                                                                                                                                Rest *P*unc \< 0.05
                                                                                            5 HC\                                                                                                                                                                                                      
                                                                                            \*61(55--66)                                                                                                                                                                                               

  ET tremor inducing motor task vs rest             ↑                                       SMA, contralateral motor cortex                                                                                                                                                                            

                                                    ↓                                       Cerebellum, visual cortex                                                                                                                                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ba, [@bb006]; cor, multiple comparison corrected; Cri, criteria; D, [@bb0031]; ET, essential tremor; Fin, [@bb0045]; FOV, field of view; HC, healthy controls; head, head tremor; ION, inferior olive nucleus; M, [@bb0079]; PMC, premotor cortices; PT, psychogenic tremor; rCBF, regional blood flow; rCMGlc, regional cerebral glucose metabolism; RN, red nucleus; SMA, supplementary motor area; SMC, sensory motor cortex; *P*unc, multiple comparison uncorrected; UE, upper extremity; voice, voice tremor; vs, versus.

###### 

Receptor scintigraphy: positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                       Clinical features    Imaging                                                                                                                                     
  -------------------------------------------------------------------- -------------------- --------------------------------------- ----------------------------------------- ----- ---- ---------------------------------------------- -----------------------------------------------------------------------
  [@bb0021], ^18^F-DOPA PET dopa transporter                           8 ET 60(10)          30 HC 63(10)\                           UE, head, jaw, legs, lips, rest           --    --   --                                             Striatal uptake with occipital reference *P* \< 0.05
                                                                                            16 PD 56(12)\                                                                                                                               
                                                                                            12 sPT 59(19)\                                                                                                                              
                                                                                            11 rest 58(11)                                                                                                                              

                                                                                                                                                                                                                                        

  [@bb004], SPECT ^123^I-beta-CIT dopamine transporter                 32 ET \*63(31--83)   30 HC \*45(21--75)\                     UE, rest, mouth, head, legs               Fi    --   --                                             Striatal uptake with cerebellar reference *P* \< 0.05
                                                                                            29 PD \*61(39--81)                                                                                                                          

                                                                                                                                                                                                                                        

  [@bb0066], SPECT ^123^I-IPT dopamine transporter                     9 PT 60.0(11.4)\     21 HC 61.8(9.7)\                        UE, jaw, voice, head, tongue, lip, rest   --    --   --                                             Basal ganglia uptake with occipital reference
                                                                       6 PT + RT\           11 PD 60.8(6.5)                                                                                                                             
                                                                       68.3(10.3)                                                                                                                                                       

  ↓                                                                    Striatal uptake      *P* \< 0.05                                                                                                                                 

                                                                                                                                                                                                                                        

  [@bb0091]^,\ 123^I-beta-CIT SPECT dopamine transporter               14 ET 69(10)         43 PD 68(8)\                            UE                                        Fa    --   --                                             Striatal uptake with cerebellar reference\
                                                                                            17 PSP 72(6)\                                                                                                                               *P* \< 0.05
                                                                                            22 HC 67(8)                                                                                                                                 

                                                                                                                                                                                                                                        

  [@bb0011], ^123^I-FP-CIT SPECT dopamine transporter                  27 ET 64.1(8.8)      35 HC 61(8.7)     158 Pdism 62.8(9.0)   UE                                        Fin   −    −                                              Striatal uptake with cerebellar reference\
                                                                                                                                                                                                                                        *P* \< 0.05

                                                                                                                                                                                                                                        

  [@bb003], ^11^C-FE-CIT PET dopamine transporter                      5 ET 60(8)           31 PD 55(13)\                           UE                                        --    --   --                                             Striatal uptake with cerebellar reference
                                                                                            8 HC 52(16)                                                                                                                                 

                                                                                                                                                                                                                                        

  [@bb00106], ^123^I-FP-CIT SPECT dopamine transporter                 10 ET 68.5(6.5)      Threshold HC                            UE, VMC                                   D     ↓    Striatal uptake                                Striatal uptake with threshold method

                                                                                                                                                                                                                                        

  [@bb00116], ^99m^Tc-Trodat-1 SPECT dopamine transporter              12 ET 52.1(14.1)     27 PD 54.3(10.3)\                       UE                                        Fin   --   --                                             Striatal uptake with occipital reference\
                                                                                            10 HC 52.5(10.7)                                                                                                                            *p*\< 0.05

                                                                                                                                                                                                                                        

  [@bb0020], ^11^C-dMP PET dopamine transporter                        6 ET 60(5)           10 HC 58(5)\                            UE                                        Fin   −    −                                              Dorsal putamen, caudate with occipital reference
                                                                                            20 PD 63(8)                                                                                                                                 

                                                                                                                                                                                                                                        

  [@bb0054] and [@bb0055], ^123^I-FP-CIT SPECT dopamine transporter    32 ET 70(7)          31 HC 64(10)\                           UE, head                                  D     ↓    Striatal uptake                                Striatal uptake with occipital reference\
                                                                                            47 PD 62(10)                                                                                                                                *P* \< 0.05

                                                                                                                                                                                                                                        

  [@bb0036], ^123^I-FP-CIT SPECT dopamine transporter                  25 ET 64(12)         46 PD 64(10)\                           UE, rest                                  L     --   --                                             Striatal uptake with occipital reference\
                                                                                            50 HC 60(15)                                                                                                                                *P* \< 0.05

                                                                                                                                                                                                                                        

  [@bb0016], ^11^C-flumazenil PET (GABA)                               8 ET 65.5(8.0)       11 HC 56.6(4.3)                         UE,\                                      Fin   ↑    Dentate nucleus, ventrolateral thalamus, LPC   Whole brain\
                                                                                                                                    head                                                                                                ROI tremor network template\
                                                                                                                                                                                                                                        FWE *P* \< 0.05

                                                                                                                                                                                                                                        

  [@bb00101], ^123^I-FP-CIT SPECT dopamine and serotonin transporter   15 ET 70.6(5.7)      15 DLB 76.6(2.3)\                       UE                                        D     --   --                                             Midbrain and striatal uptake with occipital reference, MRI alignment\
                                                                                            15 PSP 66.6(8.2)\                                                                                                                           *P* \< 0.05
                                                                                            15 PD 78.6(5.8)\                                                                                                                            
                                                                                            9 HC 74.6(2.8)                                                                                                                              

                                                                                                                                                                                                                                        

  [@bb0033], ^123^I-FP-CIT SPECT dopamine transporter                  15 ET 52.5(19.5)     21 PD 59.9(13.4)\                       UE                                        D     --   --                                             Striatal uptake with occipital reference *P* \< 0.05
                                                                                            14 DYS 52.7(16.5)\                                                                                                                          
                                                                                            17 HC 55.3(13.7)                                                                                                                            

                                                                                                                                                                                                                                        

  [@bb0047], ^123^I-FP-CIT SPECT dopamine transporter                  28 ET 64(15)         28 HC 63(11)\                           UE                                        D     ↓    Striatal uptake\                               Striatal uptake with occipital reference\
                                                                                            33 PD ?                                                                                      (less severely than in PD)                     *P* \< 0.05
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BG, basal ganglia; Cri, criteria; D, [@bb0031]; DLB, Dementia with Lewy bodies; DYS, dystonia; ET, essential tremor; Fa, [@bb0041]; Fi, [@bb0044]; Fin, [@bb0045]; FWE, familial wise error-corrected; HC, healthy controls; L, [@bb0076]; LPC, lateral premotor cortex; PD, Parkinson\'s disease; Pdism, parkinsonism; PSP, progressive supranuclear palsy; PT, postural tremor; rest, rest tremor; sn, substantia nigra; sPT, sporadic postural tremor; UE, upper extremity; VIM, ventral intermediate thalamus; VMC, impaired visuomotor coordination; vs, versus.

###### 

Functional MRI (fMRI).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Clinical features                                                  Imaging                                                                                                                                                                                                                                                    
  ----------------- ------------------------------------------------------------------ ------------------ --------------------- ----- ---------------------------------------------------------------------------- --- -------------------------------------------------------------------------------------------------------------------------- ---------------------------------------
  [@bb0022], 1.5T   12 ET 61.1(11.9)                                                   15 HC 58.2(9.8)    UE                    Fin   ET (most effected arm vs rest) and HC (mimicking tremor right arm vs rest)   ↑   Bilateral cerebellum\                                                                                                      Whole brain\
                                                                                                                                                                                                                       Bilateral red nucleus                                                                                                      *P*cor \< 0.05

                                                                                                                                                                                                                                                                                                                                                  

  [@bb0025], 1.5T   12 ET 62.2(12.4)                                                   12 HC 59.8(10.7)   UE                    D     Stroop task                                                                  ↑   Left dorsolateral prefrontal, bilateral inferior parietal cortex^\*^                                                       Whole brain\
                                                                                                                                                                                                                                                                                                                                                  FDR *P*cor \< 0.05

                                                                                                                                                                                                                                                                                                                                                  

  [@bb00125], 3T    15 ET 61.6(9.3)                                                    15 HC 60.4(7.3)    UE                    D     High vs low load verbal working memory                                       ↑   Cerebellum^\*^                                                                                                             Whole brain\
                                                                                                                                                                                                                                                                                                                                                  Connectivity seed cerebellum\
                                                                                                                                                                                                                                                                                                                                                  FWE *P*cor \< 0.05

                                                                                                                                                                                                                                                                                                                                                  

  [@bb0094], 3T     11 ET 51.5(11.8)                                                   11 HC 51.8(14.0)   UE, head, voice       D     −                                                                            ↓   CTC pathways^\*^                                                                                                           rsfMRI connectivity\
                                                                                                                                                                                                                                                                                                                                                  ROI: Cerebellum-MC vs Cerebellum-DBN\
                                                                                                                                                                                                                                                                                                                                                  1 Hz rTMS\
                                                                                                                                                                                                                                                                                                                                                  *P*cor \< 0.05

                                                                                                                                                                                                                                                                                                                                                  

  [@bb0042], 3T     20 ET 50.3(14.2)                                                   20 HC 50.3(14.2)   UE, LE, head, voice   L     --                                                                           ↓   Bilateral cerebellar lobes, bilateral thalamus (mediodorsal and ventral intermediate thalamic nucleus), insular lobe^\*^   Regional homogeneity rsfMRI\
                                                                                                                                                                                                                                                                                                                                                  *P*cor \< 0.05

  ↑                 Bilateral prefrontal, parietal cortices, left primary cortex^\*^                                                                                                                                                                                                                                                              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cor, multiple comparison corrected; Cri, criteria; CTC, cerebello-thalamo-cortical pathways; cor, multiple comparison corrected; D, [@bb0031]; DBN, default brain network; EMG, electromyography; ET, essential tremor; FDR, false discovery rate; Fin, [@bb0045]; HC, healthy controls; head, head tremor; L, [@bb0076]; LE, lower extremity; lSMA, left supplementary motor area; MC, motor cortex; PMA, primary motor area; PSA, primary sensory area; ReHo, regional homogeneity; ROI, region of interest; rs, resting state; rTMS, repetitive transcranial magnetic stimulation; UE, upper extremity; *P*unc, multiple comparison uncorrected; voice, voice tremor; vs, versus. ^\*^Not included in [fig. 2](#f0010){ref-type="fig"}
